logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5209.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Copyright © Médecins Sans Frontières
v2.1.5209.produseast1
Showing 1 - 8 of 8 Items
Showing 1 - 8 of 8 Items
Sort By: Relevance
  • Newest to oldest
  • Oldest to newest
  • Relevance
Journal Article
|
Research

Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial

Dondorp AM, Fanello CI, Hendriksen IC, Gomes E, Seni A,  et al.
2010-11-08 • Lancet
2010-11-08 • Lancet
Severe malaria is a major cause of childhood death and often the main reason for paediatric hospital admission in sub-Saharan Africa. Quinine is still the established treatment of choice...
Journal Article
|
Review

Post-licensure deployment of oral cholera vaccines: a systematic review

Martin S, Lopez AMZ, Bellos A, Deen JL, Ali MI,  et al.
2014-09-29 • Bulletin of the World Health Organization
2014-09-29 • Bulletin of the World Health Organization
OBJECTIVE
To describe and analyse the characteristics of oral cholera vaccination campaigns; including location, target population, logistics, vaccine coverage and delivery costs.
Journal Article
|
Commentary

The value of and challenges for cholera vaccines in Africa

von Seidlein L, Jiddawi MS, Grais RF, Luquero FJ, Lucas M,  et al.
2013-11-01 • Journal of Infectious Diseases
2013-11-01 • Journal of Infectious Diseases
The 21st century saw a shift in the cholera burden from Asia to Africa. The risk factors for cholera outbreaks in Africa are incompletely understood, and the traditional emphasis on prov...
Journal Article
|
Commentary

Improving rotavirus vaccine coverage: Can newer-generation and locally produced vaccines help?

Deen JL, Lopez AMZ, Kanungo S, Wang XY, Ahn DD,  et al.
2017-11-14 • Human Vaccines and Immunotherapeutics
2017-11-14 • Human Vaccines and Immunotherapeutics
There are two internationally available WHO-prequalified oral rotavirus vaccines (Rotarix and RotaTeq), two rotavirus vaccines licensed in India (Rotavac and Rotasiil), one in China (Lan...
Journal Article
|
Commentary

Public Health. The cholera crisis in Africa

Bhattacharya S, Black RE, Bourgeois L, Clemens JD, Cravioto A,  et al.
2009-05-14 • Science
2009-05-14 • Science
Journal Article
|
Research

Immunogenicity and protection from a single dose of internationally available killed oral cholera vaccine: a systematic review and meta-analysis

Lopez AMZ, Deen JL, Azman AS, Luguero FJ, Kanungo S,  et al.
2017-11-21 • Clinical Infectious Diseases
2017-11-21 • Clinical Infectious Diseases
In addition to improved water supply and sanitation, the two-dose killed oral cholera vaccine (OCV) is an important tool for the prevention and control of cholera. We aimed to document t...
Journal Article
|
Research

The case for reactive mass oral cholera vaccinations

Reyburn R, Deen JL, Grais RF, Bhattacharya S, Sur D,  et al.
2011-01-25 • PLOS Neglected Tropical Diseases
2011-01-25 • PLOS Neglected Tropical Diseases
The outbreak of cholera in Zimbabwe intensified interest in the control and prevention of cholera. While there is agreement that safe water, sanitation, and personal hygiene are ideal fo...
Journal Article
|
Research

The scenario approach for countries considering the addition of oral cholera vaccination in cholera preparedness and control plans

Deen JL, von Seidlein L, Luquero FJ, Troeger C, Reyburn R,  et al.
2016-01-01 • Lancet Infectious Diseases
2016-01-01 • Lancet Infectious Diseases
Oral cholera vaccination could be deployed in a diverse range of situations from cholera-endemic areas and locations of humanitarian crises, but no clear consensus exists. The supply of ...